Evidence map›Paper›PMID 34296202›Full record

ArticleMed (New York, N.Y.)2021

Intestinal barrier dysfunction plays an integral role in arthritis pathology and can be targeted to ameliorate disease.

Diana E Matei, Madhvi Menon, Dagmar G Alber, Andrew M Smith, Bahman Nedjat-Shokouhi, Alessio Fasano, Laura Magill, Amanda Duhlin, Samuel Bitoun, Aude Gleizes and 7 more

Open access · hybridAbstract read
In one paragraph

Article in Med (New York, N.Y.), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 68 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
68citing papers in PubMed, 1 pooled it
4.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

68 citing papers in PubMed, 1 synthesis or guideline pooled it, 102 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. The gut-joint axis in osteoarthritis.Nature reviews. Rheumatology · 2026
    Review
  8. Article
  9. Review
  10. The gut-joint axis in juvenile idiopathic arthritis.Arthritis research & therapy · 2026
    Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Total saponins ofJournal of ginseng research · 2025
    Article
  18. Microbial threads in the tapestry of rheumatoid arthritis.The Journal of clinical investigation · 2025
    Review
  19. Review
  20. Article

8 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 9 institutions in 3 countries.

Diana E MateiCentre for Rheumatology, Division of Medicine and Division of Infection and Immunity and Transplantation, University College London, London WC1E 6JF, UK.
Madhvi MenonCentre for Rheumatology, Division of Medicine and Division of Infection and Immunity and Transplantation, University College London, London WC1E 6JF, UK.
Dagmar G AlberInfection, Immunity and Inflammation Programme, UCL Great Ormond Street Institute of Child Health, London WC1N 1EH, UK.
Andrew M SmithEastman Dental Institute, School of Life and Medical Sciences, UCL, London WC1X 8LD, UK.
Bahman Nedjat-ShokouhiEastman Dental Institute, School of Life and Medical Sciences, UCL, London WC1X 8LD, UK.
Alessio FasanoMassGeneral Hospital for Children, Boston, MA 02114, USA.
Laura MagillCentre for Rheumatology, Division of Medicine and Division of Infection and Immunity and Transplantation, University College London, London WC1E 6JF, UK.
Amanda DuhlinCentre for Rheumatology, Division of Medicine and Division of Infection and Immunity and Transplantation, University College London, London WC1E 6JF, UK.
Samuel BitounRheumatology Department, Bicêtre Hospital AP-HP, Université Paris-Saclay and INSERM UMR 1184 IMVA 78 Avenue du Général Leclerc, 94270 Le Kremlin Bicêtre, France.
Aude GleizesUniversité de Paris, CNRS, INSERM, UTCBS, Unité des Technologies Chimiques et Biologiques pour la Santé, 75006 Paris, France.
Salima Hacein-Bey-AbinaUniversité de Paris, CNRS, INSERM, UTCBS, Unité des Technologies Chimiques et Biologiques pour la Santé, 75006 Paris, France.
Jessica J MansonDepartment of Rheumatology, University College London Hospital, London NW1 2BU, UK.
Elizabeth C RosserCentre for Rheumatology, Division of Medicine and Division of Infection and Immunity and Transplantation, University College London, London WC1E 6JF, UK.
ABIRISK Consortium
Nigel KleinInfection, Immunity and Inflammation Programme, UCL Great Ormond Street Institute of Child Health, London WC1N 1EH, UK.
Paul A BlairCentre for Rheumatology, Division of Medicine and Division of Infection and Immunity and Transplantation, University College London, London WC1E 6JF, UK.
Claudia MauriCentre for Rheumatology, Division of Medicine and Division of Infection and Immunity and Transplantation, University College London, London WC1E 6JF, UK.
University College London · GBCentre National de la Recherche Scientifique · FREastman Dental Hospital · GBGreat Ormond Street Hospital · GBArthritis UK · GBBroad Institute · USInserm · FRMassachusetts General Hospital · USUniversity College Hospital · GB

Funding

Medical Research Council MR/K023624/1Medical Research Council MR/L000261/1Medical Research Council MR/T000910/1Versus Arthritis 21140
6 · The paper itself

Abstract

backgroundEvidence suggests an important role for gut-microbiota dysbiosis in the development of rheumatoid arthritis (RA). The link between changes in gut bacteria and the development of joint inflammation is missing. Here, we address whether there are changes to the gut environment and how they contribute to arthritis pathogenesis.

methodsWe analyzed changes in markers of gut permeability, damage, and inflammation in peripheral blood and serum of RA patients. Serum, intestines, and lymphoid organs isolated from K/BxN mice with spontaneous arthritis or from wild-type, genetically modified interleukin (IL)-10R

findingsRA patients display increased levels of serum markers of gut permeability and

conclusionsWe suggest that breakdown of gut-barrier integrity contributes to arthritis development and propose restoration of gut-barrier homeostasis as a new therapeutic approach for RA.

fundingFunded by Versus Arthritis (21140 and 21257) and UKRI/MRC (MR/T000910/1).

Indexed as

Arthritis, RheumatoidGastrointestinal MicrobiomeIntestinal DiseasesAnimalsDysbiosisHumansInflammationIntestinal MucosaMicearthritisgut mucosagut permeabilityinflammationtherapy

Identifiers

PMID34296202
PMCPMC8280953
OpenAlexW3162655259

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.